Discover how the medicinal orchid Dendrobium officinale (Tiepi Shihu) improves salivary gland function, reduces inflammation, and rebalances oral microbiota in nasopharyngeal cancer patients ...

“What I valued most about the (NY) Quitline was their empathy,” Melvin said. “Their follow-up calls gave me the support I ...

Hyperion Functional Medicine introduces a transformative approach to cancer care through its Functional Oncology program, designed to optimize treatment, ...

First patient treated in Phase II portion of clinical trial in metastatic prostate cancer at the West Los Angeles Veterans Administration ...

Dr Reddy’s Laboratories reports 2% increase in net profit, attributing growth to new acquisitions and product launches.

The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal. Revenue increased to Rs 8,359 crore from Rs 7,215 crore a year ago.

Revlimid has arguably been the single biggest growth driver for Dr Reddy's in recent years, fueling record-high US sales last ...

China-based Kelun-Biotech Biopharmaceutical has received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed ...

LEO Pharma will be gaining the rights to commercialise Junshi Biosciences’ toripalimab in Europe under a new distribution and ...

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...

Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in ...